A CLINICAL RESEARCH STUDY IS BEING CONDUCTED FOR WOMEN EXPERIENCING MODERATE TO SEVERE ENDOMETRIAL-RELATED PAIN.
The INANNA study is evaluating an investigational medication in women with moderate or severe endometriosis pain.
You may qualify to participate if you:
• Are between 18 and 49 years of age
• Have been diagnosed with endometriosis
• Have a 21-38 day menstrual cycle
• Are not pregnant, nursing or planning a pregnancy
within the next 12 months
• Are willing to stop taking current hormonal endometriosis
therapies (use of non-hormonal contraception methods is required during the study
QUALIFIED PARTICIPANTS MAY RECEIVE:
• Study medications & examinations at no cost
• Compensation for time & travel
ENTER YOUR INFO TO JOIN
What is endometriosis?
Endometriosis is an often painful disorder in which tissue that normally lines the inside of your uterus–the endometrium–grows outside of your uterus. Endometriosis most commonly involves your ovaries, fallopian tubes, and the tissue lining your pelvis.
What is the purpose of the INANNA study?
This study is testing whether an investigational medication called MT-2990 could reduce pain associated with endometriosis. MT-2990 is different from other medications that are commonly used to treat endometriosis. It is designed to specifically target cells in the body’s immune system that cause inflammation associated with endometriosis pain. This study will help measure how effective and safe it might be in reducing that pain.
What is involved in the INANNA study?
Participation in the study will last about 1 year and will require approximately 9 visits to the research clinic and 2 scheduled follow-up phone calls.
The study is divided into several phases:
• Washout Period(around 2-3 months): Women who are using hormonal therapies will need to stop using these and will need to start using study-approved methods of birth control. You may also need to stop using certain pain-relieving medications and switch to study-approved options.
• Screening Period(around 2-3 months): Tests and assessments will be performed to determine whether you meet the criteria to participate in the study. In addition, you will need to have two menstrual cycles that are 21-38 days long during the Screening Period to be eligible to participate in the study.
• StudyTreatmentPeriod(around 4 months): You will be randomly assigned (like the flip of a coin) to study treatment with either the investigational drug or placebo (an inactive substance). You will receive the study treatment through IV infusion once each month and attend 4 other visits for tests and to check on your health.
• Follow-Up Period(around 5 months): You will receive 2 planned phone calls over this time to check up on your overall health, endometriosis-related pain, use of medications and whether you have had any hospital admissions or endometriosis-related surgeries.